Quast U, Engel J, Steffen E, Tschesche H, Kupfer S
Eur J Biochem. 1978 May 16;86(2):353-60. doi: 10.1111/j.1432-1033.1978.tb12317.x.
Modified trypsin kallikrein inhibitor (I*), with the reactive-site peptide bond Lys-15--Ala-16 split, reacts with alpha-chymotrypsin (E) via an intermediate X to the stable tetrahedral complex C:E + I in equilibrium X leads to C. Formation X constitutes a fast pre-equilibrium (equilibrium constant Kx = 7 X 10(-5) M, association rate constant kx = 4 X 10(3)M-1s-1) to the slow reaction X leads to C (rate constant kc = 2 X 10(-3) s-1), all values at pH 7.5. No intermediate X is observed when alpha-chymotrypsin reacts with I*-OMe in which the carboxyl group of Lys-15 is esterified by methanol. This observation as well as the different pH dependence of the overall association rate constants in the case of I* and I*-OMe indicate tha formation of X precedes formation of the acyl enzyme in the catalytic pathway. The data are compared to the similar results obtained with beta-trypsin and I* or I*-OMe.
活性部位肽键Lys-15--Ala-16断裂的修饰胰蛋白酶激肽释放酶抑制剂(I*),通过中间体X与α-胰凝乳蛋白酶(E)反应,生成稳定的四面体复合物C:E + I,处于平衡状态X→C。X的形成构成了向缓慢反应X→C的快速预平衡(平衡常数Kx = 7×10⁻⁵ M,缔合速率常数kx = 4×10³ M⁻¹ s⁻¹),所有值均在pH 7.5时。当α-胰凝乳蛋白酶与I*-OMe反应时未观察到中间体X,其中Lys-15的羧基被甲醇酯化。这一观察结果以及I和I-OMe情况下总缔合速率常数的不同pH依赖性表明,在催化途径中X的形成先于酰基酶的形成。将这些数据与用β-胰蛋白酶和I或I-OMe获得的类似结果进行了比较。